)
Stereotaxis (STXS) investor relations material
Stereotaxis Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Technology and innovation
Offers unique robotic solutions for minimally invasive endovascular surgery, leveraging robotic magnetic navigation (RMN) for precise catheter control and improved safety in complex anatomies.
GenesisX robot enables rapid installation and compatibility with various x-ray systems, reducing adoption barriers.
Proprietary MAGIC ablation and mapping catheters expand the product portfolio and recurring revenue opportunities.
Digital ecosystem launched with Synchrony Digital Operating Room System, integrating automation and AI for enhanced connectivity and workflow.
Acquisition of Robocath and development of EMAGIN devices extend capabilities into interventional cardiology and neurointervention.
Market opportunity and commercial presence
Addresses a total addressable market (TAM) exceeding $30B across electrophysiology, interventional cardiology, and neurointervention.
Over 100 robotic systems installed in more than 20 countries, treating 150,000+ patients globally.
Four major commercial opportunities identified: electrophysiology, interventional cardiology, neurointervention, and capital/SaaS models.
Projected revenue growth from $32M in 2025 to $40M in 2026, driven by system sales, disposable catheters, and digital solutions.
Clinical and physician impact
RMN technology delivers 72% fewer major complications, 36% less radiation exposure, and improved efficacy compared to manual procedures.
Over 500 clinical publications validate safety, efficacy, and expanded treatment options for complex arrhythmias.
Robotic approach reduces occupational hazards for physicians, enhances procedural control, and democratizes skill.
- Regulatory wins, new products, and Robocath deal drive optimism for double-digit 2026 growth.STXS
Q1 202613 May 2026 - Acquisition accelerates robotic leadership in endovascular care, targeting rapid market growth.STXS
M&A announcement15 Apr 2026 - Vote on director elections, auditor ratification, and executive compensation by May 13, 2026.STXS
Proxy filing3 Apr 2026 - Annual meeting to elect directors, ratify auditor, and approve executive compensation.STXS
Proxy filing3 Apr 2026 - Shelf registration enables up to $150 million in offerings to fund growth, with significant dilution risk.STXS
Registration Filing13 Mar 2026 - 2025 revenue rose 36% in Q4 and 20% for the year, with strong growth and margin expansion ahead.STXS
Q4 20259 Mar 2026 - Q2 revenue fell 43% on system delays, but regulatory wins and APT deal set up a stronger H2.STXS
Q2 20241 Feb 2026 - Q3 revenue up 18% to $9.2M, with strong cash and regulatory progress, but net loss widened.STXS
Q3 202415 Jan 2026 - Up to 6.1M shares registered for resale post-APT acquisition; earnout shares tied to milestones.STXS
Registration Filing16 Dec 2025
Next Stereotaxis earnings date
Next Stereotaxis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage